From: Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait
Drug
ECV (μg/μl)*
% of isolates ≤ ECV
RPMI 1640
MH-GMB
Voriconazole
1.0 (98.1%)
92 (100 %)
Posaconazole
0.25 (95 %)
91 (98.9 %)
86 (93.5 %)
Caspofungin
0.25 (95%)
92 (100%)
Amphotericin B
4.00 (99%)
89 (96.7%)